| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |